Mirimus, Inc. and Charles River Laboratories Internation, Inc. together expand their mouse engineering capabilities through a strategic partnership. Mirimus, a leader in the creation of RNA interference and application of CRISPR/Cas9 gene editing technologies, has partnered with Charles River Laboratories for production of RNAi and CRISPR-engineered mouse models. Together, we provide end-to-end service from model design, molecular engineering expertise, embryology and breeding services, in addition to a full range of drug discovery services globally.